News & Updates

Gout patients at risk of developing depression, anxiety

03 Feb 2021

The odds of developing depression and anxiety are high among patients with gout, suggest the results of a systematic review and meta-analysis.

Gout patients at risk of developing depression, anxiety

03 Feb 2021

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

02 Feb 2021

Treatment discontinuation with tofacitinib is common in patients with rheumatoid arthritis (RA) despite its ease of administration, reports a new study.

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

02 Feb 2021

Long-term tacrolimus therapy safe, effective in lupus nephritis

02 Feb 2021 by

Maintenance treatment with tacrolimus in patients with lupus nephritis (LN) over 5 years is effective and well tolerated in the real-world clinical setting, results of a postmarketing surveillance (PMS) study in Japan have shown.

Long-term tacrolimus therapy safe, effective in lupus nephritis

02 Feb 2021

Oral steroids can up CVD risk, even at low doses

31 Jan 2021 by

Use of oral glucocorticoid is associated with an increased risk of cardiovascular diseases (CVDs), even at low doses of <5 mg prednisone-equivalent daily in patients with immune-mediated inflammatory diseases, a large study reveals.

Oral steroids can up CVD risk, even at low doses

31 Jan 2021

Filgotinib scores in RA patients with limited or no MTX exposure

28 Jan 2021 by

The Janus kinase (JAK)-1 inhibitor filgotinib delivers meaningful benefits for signs and symptoms of rheumatoid arthritis (RA), as well as physical function, in patients with limited or no prior exposure to methotrexate (MTX), according to the results of the phase III FINCH 3 trial.

Filgotinib scores in RA patients with limited or no MTX exposure

28 Jan 2021

Amiselimod exhibits favourable safety in healthy individuals

27 Jan 2021 by

Amiselimod, an oral selective sphingosine 1-phosphate (S1P) receptor modulator, demonstrated a favourable safety profile among healthy individuals, according to a phase I study presented at Crohn’s and Colitis 2021.

Amiselimod exhibits favourable safety in healthy individuals

27 Jan 2021

Sexual problems in men with ankylosing spondylitis tied to disease activity

26 Jan 2021

Male patients with ankylosing spondylitis appear to have poor sexual performance, and this problem is associated with disease activity rather than sexual hormonal profile, according to a study.

Sexual problems in men with ankylosing spondylitis tied to disease activity

26 Jan 2021

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

22 Jan 2021 by

Romilkimab – a novel engineered, humanized immunoglobulin(Ig)-G4 antibody – delivers significant skin benefits for individuals with early diffuse cutaneous systemic sclerosis (dcSSc), a subtype of SSc, a phase II proof-of-concept study has shown.

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

22 Jan 2021

Acute flares do not last long on febuxostat

21 Jan 2021

In patients with gout, treatment with febuxostat does not appear to prolong the duration of acute flares, a study has shown.

Acute flares do not last long on febuxostat

21 Jan 2021

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

18 Jan 2021

Flat flexible shoes do not appear to be better than stable supportive shoes for patients with knee osteoarthritis (OA) symptoms, according to a study.

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

18 Jan 2021

News & Updates

Filter by Specialty:

Specialty:

Gout patients at risk of developing depression, anxiety

Gout patients at risk of developing depression, anxiety

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

Medication persistence shorter in new users of tofacitinib for rheumatoid arthritis

Long-term tacrolimus therapy safe, effective in lupus nephritis

Long-term tacrolimus therapy safe, effective in lupus nephritis

Oral steroids can up CVD risk, even at low doses

Oral steroids can up CVD risk, even at low doses

Filgotinib scores in RA patients with limited or no MTX exposure

Filgotinib scores in RA patients with limited or no MTX exposure

Amiselimod exhibits favourable safety in healthy individuals

Amiselimod exhibits favourable safety in healthy individuals

Sexual problems in men with ankylosing spondylitis tied to disease activity

Sexual problems in men with ankylosing spondylitis tied to disease activity

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

Acute flares do not last long on febuxostat

Acute flares do not last long on febuxostat

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?